Amitai G, Gez R, Raveh L, Bar-Ner N, Grauer E, Chapman S (2016) <br />Novel bifunctional hybrid small molecule scavengers for mitigating nerve agents toxicity<br /><i>Chemico-Biological Interactions</i> <b>259</b>: 187<br /><br />Lavon O, Eisenkraft A, Blanca M, Raveh L, Ramaty E, Krivoy A, Atsmon J, Grauer E, Brandeis R (2015) <br />Is rivastigmine safe as pretreatment against nerve agents poisoning? A pharmacological, physiological and cognitive assessment in healthy young adult volunteers<br /><i>Neurotoxicology</i> <b>49</b>: 36<br /><br />Raveh L, Eisenkraft A, Weissman BA (2014) <br />Caramiphen edisylate: An optimal antidote against organophosphate poisoning<br /><i>Toxicology</i> <b>325C</b>: 115<br /><br />Katalan S, Lazar S, Brandeis R, Rabinovitz I, Egoz I, Grauer E, Bloch-Shilderman E, Raveh L (2013) <br />Magnesium sulfate treatment against sarin poisoning: dissociation between overt convulsions and recorded cortical seizure activity<br /><i>Archives of Toxicology</i> <b>87</b>: 347<br /><br />Weissman BA, Raveh L (2011) <br />Multifunctional drugs as novel antidotes for organophosphates' poisoning<br /><i>Toxicology</i> <b>290</b>: 149<br /><br />Kronman C, Cohen O, Mazor O, Ordentlich A, Raveh L, Velan B, Shafferman A (2010) <br />Next generation OP-bioscavengers: a circulatory long-lived 4-PEG hypolysine mutant of F338A-HuAChE with optimal pharmacokinetics and pseudo-catalytic characteristics<br /><i>Chemico-Biological Interactions</i> <b>187</b>: 253<br /><br />Amitai G, Adani R, Limanovich O, Teitlboim S, Yishay S, Tveria L, Yacov G, Meshulam H, Raveh L (2008) <br />Characterization of asymmetric fluorogenic phosphonates as probes for developing organophosphorus hydrolases with broader stereoselectivity<br /><i>Chemico-Biological Interactions</i> <b>175</b>: 249<br /><br />Bloch-Shilderman E, Rabinovitz I, Egoz I, Raveh L, Allon N, Grauer E, Gilat E, Weissman BA (2008) <br />Subchronic exposure to low-doses of the nerve agent VX: physiological, behavioral, histopathological and neurochemical studies<br /><i>Toxicol Appl Pharmacol</i> <b>231</b>: 17<br /><br />Mazor O, Cohen O, Kronman C, Raveh L, Stein D, Ordentlich A, Shafferman A (2008) <br />Aging-resistant organophosphate bioscavenger based on polyethylene glycol-conjugated F338A human acetylcholinesterase<br /><i>Molecular Pharmacology</i> <b>74</b>: 755<br /><br />Raveh L, Rabinovitz I, Gilat E, Egoz I, Kapon J, Stavitsky Z, Weissman BA, Brandeis R (2008) <br />Efficacy of antidotal treatment against sarin poisoning: the superiority of benactyzine and caramiphen<br /><i>Toxicol Appl Pharmacol</i> <b>227</b>: 155<br /><br />Weissman BA, Raveh L (2008) <br />Therapy against organophosphate poisoning: the importance of anticholinergic drugs with antiglutamatergic properties<br /><i>Toxicol Appl Pharmacol</i> <b>232</b>: 351<br /><br />Kronman C, Cohen O, Raveh L, Mazor O, Ordentlich A, Shafferman A (2007) <br />Polyethylene-glycol conjugated recombinant human acetylcholinesterase serves as an efficacious bioscavenger against soman intoxication<br /><i>Toxicology</i> <b>233</b>: 40<br /><br />Cohen O, Kronman C, Raveh L, Mazor O, Ordentlich A, Shafferman A (2006) <br />Comparison of polyethylene glycol-conjugated recombinant human acetylcholinesterase and serum human butyrylcholinesterase as bioscavengers of organophosphate compounds<br /><i>Molecular Pharmacology</i> <b>70</b>: 1121<br /><br />Lundy PM, Raveh L, Amitai G (2006) <br />Development of the bisquaternary oxime HI-6 toward clinical use in the treatment of organophosphate nerve agent poisoning<br /><i>Toxicol Rev</i> <b>25</b>: 231<br /><br />Souroujon MC, Feferman T, Maiti PK, Im SH, Raveh L, Fuchs S (2004) <br />Immunotherapy of myasthenia gravis.<br /><i>Cholinergic Mechanisms, CRC Press</i> <br /><br />Raveh L, Brandeis R, Gilat E, Cohen G, Alkalay D, Rabinovitz I, Sonego H, Weissman BA (2003) <br />Anticholinergic and antiglutamatergic agents protect against soman-induced brain damage and cognitive dysfunction<br /><i>Toxicol Sci</i> <b>75</b>: 108<br /><br />Raveh L, Weissman BA, Cohen G, Alkalay D, Rabinovitz I, Sonego H, Brandeis R (2002) <br />Caramiphen and scopolamine prevent soman-induced brain damage and cognitive dysfunction<br /><i>Neurotoxicology</i> <b>23</b>: 7<br /><br />Chen R, Raveh L, Zomber G, Rabinovitz I, Cohen G, Adani R, Amitai G (2001) <br />Determination of therapeutic doses of bisquaternary oximes in large animals<br /><i>J Appl Toxicol</i> <b>21</b>: 285<br /><br />Grauer E, Alkalai D, Kapon J, Cohen G, Raveh L (2000) <br />Stress does not enable pyridostigmine to inhibit brain cholinesterase after parenteral administration<br /><i>Toxicol Appl Pharmacol</i> <b>164</b>: 301<br /><br />Raveh L, Chapman S, Cohen G, Alkalay D, Gilat E, Rabinovitz I, Weissman BA (1999) <br />The involvement of the NMDA receptor complex in the protective effect of anticholinergic drugs against soman poisoning<br /><i>Neurotoxicology</i> <b>20</b>: 551<br /><br />Allon N, Raveh L, Gilat E, Cohen E, Grunwald J, Ashani Y (1998) <br />Prophylaxis against soman inhalation toxicity in guinea pigs by pretreatment alone with human serum butyrylcholinesterase<br /><i>Toxicol Sci</i> <b>43</b>: 121<br /><br />Ashani Y, Grauer E, Grunwald J, Allon N, Raveh L (1998) <br />Current Capabilities in Extrapolating from Animal to Human the Capacity of Human Butyrylcholinesterase to Detoxify Organophosphates<br /><i>In: Structure and Function of Cholinesterases and Related Proteins - Proceedings of Sixth International Meeting on Cholinesterases</i> <b>(Doctor, B.P., Taylor, P., Quinn, D.M., Rotundo, R.L., Gentry, M.K. Eds) Plenum Publishing Corp.</b>: 255<br /><br />Saxena A, Ashani Y, Raveh L, Doctor BP (1998) <br />The Role of Oligosaccharides in the Pharmacokinetics of Cholinesterases<br /><i>In: Structure and Function of Cholinesterases and Related Proteins - Proceedings of Sixth International Meeting on Cholinesterases</i> <b>(Doctor, B.P., Taylor, P., Quinn, D.M., Rotundo, R.L., Gentry, M.K. Eds) Plenum Publishing Corp.</b>: 283<br /><br />Saxena A, Ashani Y, Raveh L, Stevenson D, Patel T, Doctor BP (1998) <br />Role of oligosaccharides in the pharmacokinetics of tissue-derived and genetically engineered cholinesterases<br /><i>Molecular Pharmacology</i> <b>53</b>: 112<br /><br />Grunwald J, Marcus D, Papier Y, Raveh L, Pittel Z, Ashani Y (1997) <br />Large-scale purification and long-term stability of human butyrylcholinesterase: a potential bioscavenger drug<br /><i>Journal of Biochemical & Biophysical Methods</i> <b>34</b>: 123<br /><br />Raveh L, Grauer E, Grunwald J, Cohen E, Ashani Y (1997) <br />The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase<br /><i>Toxicol Appl Pharmacol</i> <b>145</b>: 43<br /><br />Saxena A, Raveh L, Ashani Y, Doctor BP (1997) <br />Structure of glycan moieties responsible for the extended circulatory life time of fetal bovine serum acetylcholinesterase and equine serum butyrylcholinesterase<br /><i>Biochemistry</i> <b>36</b>: 7481<br /><br />Allon N, Raveh L, Gilat E, Grunwald J, Manistersky E, Cohen E, Ashani Y (1995) <br />Protection of Guinea Pigs against Soman Inhalation by Pretreatment Alone with Human Butyrylcholinesterase<br /><i>In Enzyme of the Cholinesterase Family - Proceedings of Fifth International Meeting on Cholinesterases</i> <b>(Quinn, D.M., Balasubramanian, A.S., Doctor, B.P., Taylor, P., Eds) Plenum Publishing Corp.</b>: 398<br /><br />Amitai G, Rabinovitz I, Zomber G, Chen R, Cohen G, Adani R, Raveh L (1995) <br />Bisquaternary Oximes as Antidotes against Tabun and Soman Poisoning<br /><i>In Enzyme of the Cholinesterase Family - Proceedings of Fifth International Meeting on Cholinesterases</i> <b>(Quinn, D.M., Balasubramanian, A.S., Doctor, B.P., Taylor, P., Eds) Plenum Publishing Corp.</b>: 345<br /><br />Grauer E, Raveh L, Kapon J, Grunwald J, Cohen E, Ashani Y (1995) <br />Human Butyrylcholinesterase as Prophylaxis Treatment against Soman<br /><i>In Enzyme of the Cholinesterase Family - Proceedings of Fifth International Meeting on Cholinesterases</i> <b>(Quinn, D.M., Balasubramanian, A.S., Doctor, B.P., Taylor, P., Eds) Plenum Publishing Corp.</b>: 400<br /><br />Kadar T, Raveh L, Brandeis R, Grunwald J, Cohen E, Ashani Y (1995) <br />Prevention of Brain Damage and Behavioral Performance Changes following an IV Injection of Soman and VX in Rats Pretreated with Human Butyrylcholinesterase<br /><i>In Enzyme of the Cholinesterase Family - Proceedings of Fifth International Meeting on Cholinesterases</i> <b>(Quinn, D.M., Balasubramanian, A.S., Doctor, B.P., Taylor, P., Eds) Plenum Publishing Corp.</b>: 404<br /><br />Raveh L, Grunwald J, Cohen E, Ashani Y (1995) <br />Efficacy of Prophylaxis with Human Butyrylcholinesterase against Soman and VX Poisoning<br /><i>In Enzyme of the Cholinesterase Family - Proceedings of Fifth International Meeting on Cholinesterases</i> <b>(Quinn, D.M., Balasubramanian, A.S., Doctor, B.P., Taylor, P., Eds) Plenum Publishing Corp.</b>: 402<br /><br />Caranto GR, Waibel KH, Asher JM, Larrison RW, Brecht KM, Schutz MB, Raveh L, Ashani Y, Wolfe AD, Maxwell DM, Doctor BP (1994) <br />Amplification of the effectiveness of acetylcholinesterase for detoxification of organophosphorus compounds by bis-quaternary oximes<br /><i>Biochemical Pharmacology</i> <b>47</b>: 347<br /><br />Grunwald J, Raveh L, Doctor BP, Ashani Y (1994) <br />Huperzine A as a pretreatment candidate drug against nerve agent toxicity<br /><i>Life Sciences</i> <b>54</b>: 991<br /><br />Brandeis R, Raveh L, Grunwald J, Cohen E, Ashani Y (1993) <br />Prevention of soman-induced cognitive deficits by pretreatment with human butyrylcholinesterase in rats<br /><i>Pharmacol Biochem Behav</i> <b>46</b>: 889<br /><br />Raveh L, Grunwald J, Marcus D, Papier Y, Cohen E, Ashani Y (1993) <br />Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity. In vitro and in vivo quantitative characterization<br /><i>Biochemical Pharmacology</i> <b>45</b>: 2465<br /><br />Raveh L, Segall Y, Leader H, Rothschild N, Levanon D, Henis Y, Ashani Y (1992) <br />Protection against tabun toxicity in mice by prophylaxis with an enzyme hydrolyzing organophosphate esters<br /><i>Biochemical Pharmacology</i> <b>44</b>: 397<br /><br />Ashani Y, Rothschild N, Segall Y, Levanon D, Raveh L (1991) <br />Prophylaxis against organophosphate poisoning by an enzyme hydrolysing organophosphorus compounds in mice<br /><i>Life Sciences</i> <b>49</b>: 367<br /><br />Ashani Y, Shapira S, Levy D, Wolfe AD, Doctor BP, Raveh L (1991) <br />Butyrylcholinesterase and acetylcholinesterase prophylaxis against soman poisoning in mice<br /><i>Biochemical Pharmacology</i> <b>41</b>: 37<br /><br />Doctor BP, Raveh L, Wolfe AD, Maxwell DM, Ashani Y (1991) <br />Enzymes as pretreatment drugs for organophosphate toxicity<br /><i>Neurosci Biobehav Rev</i> <b>15</b>: 123<br /><br />Shapira S, Kadar T, Cohen G, Chapman S, Raveh L (1990) <br />Effects of CBDP and MEPQ on the toxicity and distribution of [3H]-soman in mice<br /><i>Archives of Toxicology</i> <b>64</b>: 663<br /><br />Raveh L, Ashani Y, Levy D, De La Hoz DM, Wolfe AD, Doctor BP (1989) <br />Acetylcholinesterase prophylaxis against organophosphate poisoning. Quantitative correlation between protection and blood-enzyme level in mice<br /><i>Biochemical Pharmacology</i> <b>38</b>: 529<br /><br />Ashani Y, Leader H, Raveh L, Bruckstein R, Spiegelstein M (1983) <br />In vitro and in vivo protection of acetylcholinesterase against organophosphate poisoning by pretreatment with a novel derivative of 1,3,2-dioxaphosphorinane 2-oxide<br /><i>Journal of Medicinal Chemistry</i> <b>26</b>: 145<br /><br />